Found: 5
Select item for more details and to access through your institution.
Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors.
- Published in:
- SCIENCE CHINA Life Sciences, 2023, v. 66, n. 1, p. 94, doi. 10.1007/s11427-021-2140-8
- By:
- Publication type:
- Article
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19349-w
- By:
- Publication type:
- Article
Understanding the Global Cancer Statistics 2018: implications for cancer control.
- Published in:
- SCIENCE CHINA Life Sciences, 2021, v. 64, n. 6, p. 1017, doi. 10.1007/s11427-019-9816-1
- By:
- Publication type:
- Article
LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP.
- Published in:
- SCIENCE CHINA Life Sciences, 2020, v. 63, n. 3, p. 419, doi. 10.1007/s11427-019-9581-8
- By:
- Publication type:
- Article
Conservative medical intervention as a complement to CDT for BCRL therapy: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1361128
- By:
- Publication type:
- Article